About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
729 genotypes with 924 annotations displayed of selected term and subterms
Searched Term: increased lymphoma incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Abraxas1tm1.1Bwng/Abraxas1+
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased histiocytic sarcoma incidence J:269823
increased lymphoma incidence J:269823
Abraxas1tm1.1Bwng/Abraxas1tm1.1Bwng
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N) 		increased lymphoma incidence J:269823
Aicdatm1(cre)Mnz/Aicda+
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
increased follicular lymphoma incidence J:153656
increased T cell derived lymphoma incidence J:153656
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn) 		increased B cell derived lymphoma incidence J:115076
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:276210
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:276210
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N) 		increased lymphoma incidence J:193232
increased T cell derived lymphoma incidence J:193232
Anxa7tm1Pll/Anxa7+
(B6.Cg-Anxa7tm1Pll) 		increased lymphoma incidence J:93685
Apctm1Rak/Apc+
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:53451
Apex1tm1Ecf/Apex1+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		increased lymphoma incidence J:70397
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:176672
increased T cell derived lymphoma incidence J:176672
Atmtm1.1Mmpl/Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:226414
Atmtm1Awb/Atm+
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		increased T cell derived lymphoma incidence J:34193
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell derived lymphoma incidence J:103922
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
Atmtm1Awb/Atmtm1Awb
(CByJ.129S6-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
Atmtm1Awb/Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x B6.129S6-Atmtm1Awb)F1 or (B6.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
Atmtm1Awb/Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x A.129S6-Atmtm1Awb)F1 or (A.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J) 		increased T cell derived lymphoma incidence J:226414
Atmtm1Awb/Atmtm1Awb
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Atmtm1Awb/Atmtm1Awb
Rad52tm1Aps/Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:35914
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:61201
Atmtm1Led/Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		increased T cell derived lymphoma incidence J:69726
Atmtm1Mfl/Atm+
(involves: 129T2/SvEms * C57BL/6J) 		increased lymphoma incidence J:78527
Atmtm1Mfl/Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J) 		increased T cell derived lymphoma incidence J:69726
Atmtm1Pmc/Atmtm1Pmc
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:47752
Atmtm2.1Fwa/Atmtm2.1Fwa
Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:277750
Atmintm1.1Jhh/Atmintm1.1Jhh
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Cd79atm1(cre)Reth/Cd79a+
Tg(IghMyc)22Bri/0
(B6.Cg-Bcl2l11tm1.1Ast Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri) 		increased lymphoma incidence J:230105
AurkaGt(XQ0149)Wtsi/Aurka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:143099
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid) 		increased T cell derived lymphoma incidence J:102141
Badtm1Sjk/Badtm1Sjk
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6)) 		increased B cell derived lymphoma incidence J:84987
increased lymphoma incidence J:84987
Bap1em3Test/Bap1+
(involves: FVB) 		increased lymphoma incidence J:231692
Bcl2tm2.1Lbox/Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:175730
increased follicular lymphoma incidence J:175730
Bcl2l11tm1.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
increased T cell derived lymphoma incidence J:186117
Bcl2l11tm1.1Boui/Bcl2l11tm1.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm2.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm2.1Boui/Bcl2l11tm2.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm3.1Boui/Bcl2l11+
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl2l11tm3.1Boui/Bcl2l11tm3.1Boui
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117
Bcl11btm2.1Jpk/Bcl11b+
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		increased lymphoma incidence J:210122
Becn1tm1Blev/Becn1+
(involves: 129X1/SvJ * C57BL/6J) 		increased follicular lymphoma incidence J:86953
increased histiocytic sarcoma incidence J:86953
increased lymphoma incidence J:86953
Becn1tm1Htz/Becn1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:86982
Bin1tm1Gcp/Bin1tm2Gcp
Tg(MMTV-Myc)141-3Led/0
Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL) 		increased lymphoma incidence J:117330
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:133313
Blmtm1Ches/Blmtm3Brd
(involves: 129S/SvEv * C57BL/6 * NIH Black Swiss) 		increased lymphoma incidence J:86827
Blmtm3Brd/Blmtm3Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:66261
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:94768
Bmftm1.1Ast/Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst) 		increased T cell derived lymphoma incidence J:133084
Boktm1.1Ast/Boktm1.1Ast
Tg(IghMyc)22Bri/0
(involves: BALB/cJ * C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:203179
Bomb1NSF/N/Bomb1NSF/N
(involves: NFS/N * SL/Kh) 		increased lymphoma incidence J:55364
Bomb1SL/Kh/Bomb1SL/Kh
(involves: NFS/N * SL/Kh) 		increased lymphoma incidence J:55364
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:81541
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:81541
Brca1tm2Mak/Brca1tm2Mak
Chek2tm1Mak/Chek2tm1Mak
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Trp53tm1Brd/Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
Brca1tm3Cxd/Brca1tm3Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:94114
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:155810
increased T cell derived lymphoma incidence J:155810
Brca2tm1Cam/Brca2tm1Cam
(involves: 129S/SvEv * MF1) 		increased T cell derived lymphoma incidence J:46812
Brca2tm1Cbl/Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)) 		increased T cell derived lymphoma incidence J:44386
Brca2tm1Hst/Brca2tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:82434
Brca2tm1Mak/Brca2tm2Mak
Trp53tm1Brd/Trp53tm1Brd
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased lymphoma incidence J:79697
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:227115
Bub1tm1.1Jvd/Bub1tm2Jvd
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:135093
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6) 		increased B cell derived lymphoma incidence J:201641
increased lymphoma incidence J:201641
Ccnctm1.1Pisc/Ccnctm1.1Pisc
Tg(Lck-LMO1)11Sjk/0
Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:217695
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased T cell derived lymphoma incidence J:88120
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:160931
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:228288
Cd19tm1(cre)Cgn/Cd19+
Inpp5dtm1Rav/Inpp5dtm1Rav
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased follicular lymphoma incidence J:166155
increased lymphoma incidence J:166155
increased splenic marginal zone lymphoma incidence J:166155
Cd19tm1(cre)Cgn/Cd19+
Mirc30tm1.1Rdf/Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Cd19tm1(cre)Cgn/Cd19+
Ptpn11tm1Ckq/Ptpn11+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:177285
Cd28tm1Mak/Cd28tm1Mak
Rc3h1san/Rc3h1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
Cd44tm1Mak/Cd44tm1Mak
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J) 		increased lymphoma incidence J:76201
Cdc20tm1.1Pzg/Cdc20+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:150421
Cdk5rap2an/Cdk5rap2an
Tyrp1B-lt/Tyrp1B-lt
(WBB6F1) 		increased histiocytic sarcoma incidence J:102334
Cdk6tm1Phin/Cdk6+
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:144975
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:70894
increased histiocytic sarcoma incidence J:70894
increased T cell derived lymphoma incidence J:70894
Cdkn1btm1Mlf/Cdkn1b+
Crebbptm1Jvd/Crebbptm1Jvd
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * CBA * FVB) 		increased T cell derived lymphoma incidence J:88323
Cdkn1btm1Mlf/Cdkn1b+
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Trp53tm1Brd/Trp53tm1Brd
(involves: C3H * C57BL/6J * NIH) 		increased T cell derived lymphoma incidence J:87536
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased T cell derived lymphoma incidence J:87536
Cdkn2atm1(GFP)Cjs/Cdkn2atm1(GFP)Cjs
(involves: 129S1/Sv * C57BL/6) 		increased histiocytic sarcoma incidence J:87339
increased lymphoma incidence J:87339
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:44427
increased T cell derived lymphoma incidence J:44427
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)68Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lymphoma incidence J:99991
Cdkn2atm1Cjs/Cdkn2atm1Cjs
Sclt1Tg(CAG-sb10)1Dla/0
TgTn(sb-T2/Onc)76Dla/0
(involves: 129X1/SvJ * FVB/N) 		increased lymphoma incidence J:99991
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N) 		increased small lymphocytic lymphoma incidence J:88365
Cdkn2atm1Rdp/Cdkn2a+
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:120065
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:53805
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		increased lymphoma incidence J:88365
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:131914
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL) 		increased lymphoma incidence J:130397
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:120065
Cdkn2atm2.1Brn/Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:71393
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased lymphoma incidence J:88365
increased small lymphocytic lymphoma incidence J:88365
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:131914
Cdkn2btm1Bbd/Cdkn2btm1Bbd
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased lymphoma incidence J:63299
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:63299
increased T cell derived lymphoma incidence J:63299
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:146176
increased T cell derived lymphoma incidence J:146176
Chek2tm1Mak/Chek2tm1Mak
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Chfrtm1Jc/Chfr+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:97428
Chfrtm1Jc/Chfrtm1Jc
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:97428
Cks1btm1Sir/Cks1b+
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
Col1a1tm1(CAG-Mir22)Ppp/Col1a1tm1(CAG-Mir22)Ppp
Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:199366
Col1a1tm3(tetO-GFP/RNAi:Apc)Slowe/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:171191
increased T cell derived lymphoma incidence J:171191
Col1a1tm4(tetO-GFP/RNAi:Apc)Slowe/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:171191
increased T cell derived lymphoma incidence J:171191
Cop1Gt(XR0653)1.1Wtsi/Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:178271
increased histiocytic sarcoma incidence J:178271
increased T cell derived lymphoma incidence J:178271
Crebbptm1Dli/Crebbp+
(involves: 129S6/SvEvTac * C57BL/6) 		increased histiocytic sarcoma incidence J:60630
Crebbptm1Jvd/Crebbptm1Jvd
Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:105505
Crebbptm1Jvd/Crebbptm1Jvd
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB) 		increased T cell derived lymphoma incidence J:88323
Crkltm1Hkp/Crkltm1Hkp
Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:83086
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:170976
Cul9tm1.2Yxi/Cul9+
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
increased lymphoma incidence J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:170976
increased lymphoma incidence J:170976
Dclre1atm1Rleg/Dclre1a+
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
increased lymphoma incidence J:102381
Dclre1atm1Rleg/Dclre1atm1Rleg
(involves: 129S7/SvEvBrd) 		increased histiocytic sarcoma incidence J:102381
increased lymphoma incidence J:102381
Dclre1atm1Rleg/Dclre1atm1Rleg
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:102381
increased T cell derived lymphoma incidence J:102381
Dcntm1Ioz/Dcn+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased T cell derived lymphoma incidence J:53511
Dcntm1Ioz/Dcntm1Ioz
Trp53tm1Brd/Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased T cell derived lymphoma incidence J:53511
Del(4Cdkn2a-Cdkn2b)1Brn/+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:125189
Del(4Cdkn2a-Cdkn2b)2Brn/+
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:125189
Del(4D4Mit190-D4Mit51)2Aam/+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:121726
Del(14Trim13-Dleu2)4Rdf/+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Del(14Trim13-Rnaseh2b)6Rdf/+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased B cell derived lymphoma incidence J:81054
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1+
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
Dna2tm1.1Lzhg/Dna2+
(involves: 129S1/Sv) 		increased lymphoma incidence J:198831
Dnmt1tm1(tetO-BCL2)Sjk/Dnmt1+
Tg(IghMyc)22Bri/0
Tg(MMTVtTA)1Mam/0
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:93549
Dnmt1tm1Jae/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
Dnmt1tm1Jae/Dnmt1tm1Pwl
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
Dnmt1tm1Pwl/Dnmt1+
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:163407
E2f1tm1Meg/E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		increased T cell derived lymphoma incidence J:33100
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:33099
increased lymphoma incidence J:33099
Eaf2tm1Zhow/Eaf2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:145228
Eaf2tm1Zhow/Eaf2tm1Zhow
(involves: 129P2/OlaHsd * C57BL/6J) 		increased B cell derived lymphoma incidence J:145228
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6) 		increased T cell derived lymphoma incidence J:123870
Emv30b/Emv30b
Prkdcscid/Prkdcscid
(NOD.Cg-Emv30b Prkdcscid/Dvs) 		increased T cell derived lymphoma incidence J:29951
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+
(involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J) 		increased T cell derived lymphoma incidence J:112696
Esl1NFS/N/Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Esl1SL/Kh/Esl1SL/Kh
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Espl1Gt(XL058)Byg/Espl1+
Trp53tm1Tyj/Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg) 		increased lymphoma incidence J:174926
Ewsr1tm1(ERG)Thr/Ewsr1+
Rag1tm1(cre)Thr/Rag1+
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:98679
Exo1tm1Wed/Exo1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:82426
Exo1tm2Wed/Exo1tm2Wed
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:198719
Exo1tm3.1Wed/Exo1tm3.1Wed
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:198719
Exo1tm3.1Wed/Exo1tm3.1Wed
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:198719
Ezh2tm1.1Nesh/Ezh2+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
Ezh2tm1.1Nesh/Ezh2tm1.1Nesh
Cd19tm1(cre)Cgn/Cd19+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:239472
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6)) 		increased lymphoma incidence J:112563
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased histiocytic sarcoma incidence J:153501
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified) 		increased histiocytic sarcoma incidence J:178645
increased lymphoma incidence J:178645
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified) 		increased histiocytic sarcoma incidence J:178645
increased lymphoma incidence J:178645
Fbxw7tm1Iaai/Fbxw7tm1Iaai
Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:137138
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:128523
Fbxw7tm1Kei/Fbxw7tm1Kei
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:128523
increased T cell derived lymphoma incidence J:128523
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased B cell derived lymphoma incidence J:244082
increased lymphoma incidence J:244082
increased T cell derived lymphoma incidence J:244082
Fen1tm1Rak/Fen1+
(involves: 129/Sv * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:77962
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:138901
Fhittm1Tko/Fhit+
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
increased lymphoma incidence J:93269
Fhittm1Tko/Fhittm1Tko
(involves: 129X1/SvJ) 		increased B cell derived lymphoma incidence J:93269
increased lymphoma incidence J:93269
FlcnGt(RRX115)Byg/Flcn+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:147582
Flt3tm2.1Dosm/Flt3+
(B6.129(C)-Flt3tm2.1Dosm) 		increased B cell derived lymphoma incidence J:205200
increased histiocytic sarcoma incidence J:205200
Foc1NFS/N/Foc1NFS/N
(involves: SL/Kh * NFS/N) 		increased B cell derived lymphoma incidence J:16441
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased T cell derived lymphoma incidence J:118179
Foxq1sa/Foxq1sa
Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl) 		increased lymphoma incidence J:5311
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:193993
Grb2tm1Paw/Grb2+
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:93530
Grb2tm1Paw/Grb2+
Ptentm2Mak/Ptentm2Mak
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:93530
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3tm1.2Tno
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:130367
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:167612
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)) 		increased histiocytic sarcoma incidence J:172031
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased lymphoma incidence J:170965
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:160931
Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu/Gt(ROSA)26Sor+
Tg(Lck-cre)548Jxm/0
(B6.Cg-Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu Tg(Lck-cre)548Jxm) 		increased T cell derived lymphoma incidence J:185287
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP2)H27Brd/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:166063
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP2)H32Brd/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:166063
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP2)S1Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased lymphoma incidence J:166063
Gt(ROSA)26Sortm1(pb)Peli/Gt(ROSA)26Sor+
TgTn(pb-sb-ATP2)S2Brd/0
(involves: 129S7/SvEvBrd * FVB) 		increased lymphoma incidence J:166063
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Tg(MMTV-cre)#Tfln/0
Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased lymphoma incidence J:170898
increased T cell derived lymphoma incidence J:170898
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased lymphoma incidence J:170898
increased T cell derived lymphoma incidence J:170898
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:166283
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
Hprt1tm1(sb-Onco-Array)Peli/Hprt1+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:166283
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:102234
increased lymphoma incidence J:102234
increased T cell derived lymphoma incidence J:102234
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased B cell derived lymphoma incidence J:153656
increased lymphoma incidence J:153656
increased T cell derived lymphoma incidence J:153656
Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J) 		increased lymphoma incidence J:163919
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		increased B cell derived lymphoma incidence J:185598
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
Tg(GFP/KRAS2/ALPP)1Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:127226
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased B cell derived lymphoma incidence J:137122
Gt(ROSA)26Sortm2.1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J) 		increased T cell derived lymphoma incidence J:153656
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Npm1tm1Gsva/Npm1+
TgTn(pb-sb-GrOnc)#aGsva/0
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
increased lymphoma incidence J:172071
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:167612
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:191824
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ) 		increased B cell derived lymphoma incidence J:181546
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:181546
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sor+
Tg(Tek-cre)1Ywa/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai
Tg(Tek-cre)1Ywa/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
H2u/H2u
Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J) 		increased T cell derived lymphoma incidence J:92992
H2u/H2u
Tg(TCRA)B1Jg/0
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg) 		increased T cell derived lymphoma incidence J:92992
H2axtm1Fwa/H2ax+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
increased lymphoma incidence J:84879
increased T cell derived lymphoma incidence J:84879
H2axtm1Fwa/H2axtm1Fwa
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:84879
H2axtm1Fwa/H2axtm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:84879
increased T cell derived lymphoma incidence J:84879
H2axtm1Nus/H2axtm1Nus
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:86590
Hace1tm1Pngr/Hace1tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:125183
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa) 		increased histiocytic sarcoma incidence J:296531
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:194769
Hephl1cw/Hephl1cw
(CWD/LeJ) 		increased B cell derived lymphoma incidence J:24875
increased lymphoma incidence J:24875
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:81448
Hip1tm4Tsr/Hip1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:151974
Hmga1tm1Afus/Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:106702
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:79734
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
Xpatm1Tnka/Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:79734
Icostm1Flv/Icostm1Flv
Rc3h1san/Rc3h1+
(involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
Id1tm1Zhu/Id1tm1Zhu
Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased T cell derived lymphoma incidence J:44278
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts) 		increased lymphoma incidence J:77491
increased T cell derived lymphoma incidence J:77491
Ifngtm1Ts/Ifngtm1Ts
Prf1tm1Sdz/Prf1tm1Sdz
(C.Cg-Prf1tm1Sdz Ifngtm1Ts) 		increased B cell derived lymphoma incidence J:77491
increased lymphoma incidence J:77491
Igh-Vtm1(Igh-Vx24)Hmb/Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:54380
increased T cell derived lymphoma incidence J:54380
Ightm1(Myc)Janz/Igh+
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:160845, J:96785
Ightm1(Myc)Janz/Igh+
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:150341
increased lymphoma incidence J:150341
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)A5Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)D3Wmk/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:160845
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
Ighatm1(Myc)Janz/Igha+
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:90901
Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:98937
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		increased lymphoma incidence J:80859
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghMyc)22Bri/0
(involves: 129S2/SvPas * C57BL * SJL) 		increased lymphoma incidence J:187318
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		increased T cell derived lymphoma incidence J:84569
Ikzf1tm1(Pax5)Mbu/Ikzf1+
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:118111
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:118111
increased T cell derived lymphoma incidence J:118111
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale) 		increased lymphoma incidence J:208211
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
Il7rtm1.1(icre)Hrr/Il7r+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:209928
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD2-icre)4Kio/?
(involves: C57BL/10 * CBA/Ca) 		increased T cell derived lymphoma incidence J:209927
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:50626
Ing1Gt(OST206270)Lex/Ing1+
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:118602
Ing1tm1Avg/Ing1tm1Avg
(involves: 129S1/Sv * C57BL/6) 		increased B cell derived lymphoma incidence J:105658
Ing2tm1.1Ccha/Ing2tm1.1Ccha
(involves: 129 * C57BL/6J * FVB/N) 		increased histiocytic sarcoma incidence J:167311
Ino80tm1.1Schg/Ino80+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:221224
Inpp5dm1Anu/Inpp5dm1Anu
(C57BL/6JAnu-Inpp5dm1Anu) 		increased B cell derived lymphoma incidence J:104190
Irf1tm1Mak/Irf1tm1Mak
(B6.129S2-Irf1tm1Mak/J) 		increased lymphoma incidence J:91927
Irf1tm1Mak/Irf1tm1Mak
Trp53tm1Sia/Trp53tm1Sia
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased lymphoma incidence J:55418
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		increased lymphoma incidence J:36038
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
Is(14)1Rdf/Is(14)1Rdf
Is(14)5Rdf/Is(14)5Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased lymphoma incidence J:179879
increased small lymphocytic lymphoma incidence J:179879
Kat5tm1Jwl/Kat5+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Kat5tm1Jwl/Kat5+
Tg(IghMyc)22Bri/0
Trp53tm1Tyj/Trp53+
(involves: 129 * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Klf14em1Cgw/Klf14em1Cgw
(C57BL/6J-Klf14em1Cgw) 		increased lymphoma incidence J:227200
Klrk1tm1Dhr/Klrk1tm1Dhr
Tg(IghMyc)22Bri/?
(involves: C57BL/6 * CD-1) 		increased B cell derived lymphoma incidence J:134509
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
Kmt2atm1Thr/Kmt2a+
Mllt3tm2Thr/Mllt3+
Tg(Lck-cre)1Thr/?
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:100794
Kmt2atm2(MLLT3)Thr/Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased B cell derived lymphoma incidence J:110241
Kmt2dtm1.1Kaig/Kmt2d+
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Ighg1tm1(cre)Cgn/Ighg1+
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased B cell derived lymphoma incidence J:228913
increased follicular lymphoma incidence J:228913
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
Krastm2Tyj/Kras+
(involves: 129S2/SvPas) 		increased lymphoma incidence J:129627
increased T cell derived lymphoma incidence J:68981
Krastm2Tyj/Kras+
Trp53tm1Glo/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:129627
Krastm2Tyj/Kras+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
Krastm2Tyj/Kras+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
Krastm3Tyj/Kras+
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:68981
Krastm3Tyj/Kras+
Mir21atm1.1Eno/Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:164198
Krastm3Tyj/Krastm3Tyj
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:237900
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		increased lymphoblastic lymphoma incidence J:88163
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:98936
Lig1tm3Dwm/Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:77902
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased lymphoma incidence J:63078
Lig4tm1Icrf/Lig4tm1Icrf
Trp53tm1Tyj/Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)) 		increased B cell derived lymphoma incidence J:111068
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:157574
ll/ll
X/Yaa
(BXSB/MpJScr-ll) 		increased lymphoma incidence J:10973
increased T cell derived lymphoma incidence J:10973
llaSL/Kh/llaSL/Kh
(involves: AKR/JMs * SL/Kh) 		increased lymphoma incidence J:41197, J:33016
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		increased histiocytic sarcoma incidence J:307289
increased lymphoma incidence J:307289
LyarGt(RRG292)Byg/LyarGt(RRG292)Byg
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:263530
LyrBALB/cHeA/LyrBALB/cHeA
(involves: BALB/cHeA * STS/A) 		increased lymphoma incidence J:10558
Lzts1tm1Cro/Lzts1+
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:119989
Lzts1tm1Cro/Lzts1tm1Cro
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:119989
Mapkapk5tm1Pqs/Mapkapk5+
Tg(SV40-NRAS*G12D)1Sco/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:117893
Mapkapk5tm1Pqs/Mapkapk5tm1Pqs
Tg(SV40-NRAS*G12D)1Sco/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:117893
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/?
(involves: 129S4/SvJae * C57BL/6 * Swiss Webster) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
MclrRF/J/MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
MclrSWR/J/MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:165667
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4chaos3/Mcm4chaos3
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased lymphoma incidence J:165667
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4chaos3/Mcm4Gt(RRE056)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased lymphoma incidence J:165667
Mcm3tm1.1Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:227638
Mcm3tm1.2Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:227638
Mcm4chaos3/Mcm4chaos3
(involves: C57BL/6J) 		increased lymphoma incidence J:165667
increased T cell derived lymphoma incidence J:165667
Mdm2tm1.1Ypz/Mdm2tm1.1Ypz
Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri) 		increased lymphoma incidence J:164200
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:189297
increased T cell derived lymphoma incidence J:189297
Mdm2tm3.1Glo/Mdm2tm3.1Glo
(B6.129S6-Mdm2tm3.1Glo) 		increased lymphoma incidence J:164201
Mdm2tm3.1Glo/Mdm2tm3.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo) 		increased histiocytic sarcoma incidence J:164201
increased lymphoma incidence J:164201
Mdm2tm4.1Glo/Mdm2tm4.1Glo
Trp53tm3.1Glo/Trp53+
(B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo) 		increased histiocytic sarcoma incidence J:164201
increased lymphoma incidence J:164201
Mdm4tm1Glo/Mdm4+
Tg(IghMyc)22Bri/0
(involves: 129S6/SvEvTac * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:123661
Mef2btm2Rdf/Mef2b+
Tg(BCL2/IGH)M23Tjd/0
Tg(Cr2-cre)3Cgn/0
(involves: C3H/He * C57BL/6) 		increased follicular lymphoma incidence J:265465
increased lymphoma incidence J:265465
Mef2btm2Rdf/Mef2b+
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:265465
Mettm1Gvw/Met+
(involves: 129 * C57BL/6J) 		increased histiocytic sarcoma incidence J:94722
increased lymphoma incidence J:94722
Mettm2Gvw/Met+
(involves: 129 * C57BL/6J) 		increased histiocytic sarcoma incidence J:94722
increased lymphoma incidence J:94722
Mettm4Gvw/Met+
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:94722
Mgmttm1Mse/Mgmttm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
Mgmttm1Mse/Mgmttm1Mse
Mlh1tm1Mse/Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173230
increased follicular lymphoma incidence J:173230
increased T cell derived lymphoma incidence J:173230
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		increased follicular lymphoma incidence J:173671
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		increased B cell derived lymphoma incidence J:223213
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		increased B cell derived lymphoma incidence J:156946
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:34291
Mlh1tm1Lisk/Mlh1tm1Lisk
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:75745
Mlh1tm1Mse/Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
Mlh1tm1Rak/Mlh1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:53451
increased T cell derived lymphoma incidence J:53451
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:98929, J:53451
increased lymphoma incidence J:53451
increased T cell derived lymphoma incidence J:53451
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:133352
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased lymphoma incidence J:153684
increased T cell derived lymphoma incidence J:153684
Mlh1tm1Wed/Mlh1tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:133352
Mre11atm1Jpt/Mre11a+
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Mre11atm1Jpt/Mre11atm1Jpt
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Msh2tm1Htr/Msh2tm1Htr
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		increased T cell derived lymphoma incidence J:27469
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:45433
increased T cell derived lymphoma incidence J:45433
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd * FVB) 		increased lymphoma incidence J:45433
increased T cell derived lymphoma incidence J:45433
Msh2tm1Htr/Msh2tm1Htr
Smug1tm1a(EUCOMM)Hmgu/Smug1tm1a(EUCOMM)Hmgu
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:197809
Msh2tm1Htr/Msh2tm1Htr
Smug1tm1a(EUCOMM)Hmgu/Smug1tm1a(EUCOMM)Hmgu
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:197809
Msh2tm1Mak/Msh2+
Mutyhtm1Jhmi/Mutyhtm1Jhmi
Ogg1tm1Tld/Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
Msh2tm1Mak/Msh2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:28397
Msh2tm1Mak/Msh2tm1Mak
Mutyhtm1Jhmi/Mutyhtm1Jhmi
Ogg1tm1Tld/Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
Msh2tm1Rak/Msh2+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:64667
Msh2tm1Rak/Msh2tm1Rak
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:64667
Msh2tm1Rak/Msh2tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:98929
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6) 		increased lymphoma incidence J:86278
Msh2tm1Wed/Msh2tm1Wed
(involves: 129 * C57BL/6 * SJL) 		increased lymphoma incidence J:88092
Msh2tm1Whl/Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
Msh2tm2.1Rak/Msh2tm2.1Rak
Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:161577
Msh2tm2.2Rak/Msh2tm2.2Rak
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:161577
Msh3tm1Htr/Msh3tm1Htr
Msh6tm1Htr/Msh6tm1Htr
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:59561
Msh3tm1Rak/Msh3tm1Rak
Msh6tm1Rak/Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:60604
Msh6tm1Htr/Msh6tm1Htr
(involves: 129P2/OlaHsd * FVB/N) 		increased lymphoma incidence J:59561
Msh6tm1Rak/Msh6tm1Rak
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:44428
Msh6tm1Wed/Msh6+
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:92555
Msh6tm1Wed/Msh6tm1Wed
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:92555
Msmr1SL/Kh/Msmr1SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased lymphoma incidence J:34941
Msmr1SL/Kh/Msmr1SL/Kh
Msmr2SL/Kh/Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased B cell derived lymphoma incidence J:34941
Msmr2SL/Kh/Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh) 		increased lymphoma incidence J:34941
Mtbptm1Glo/Mtbp+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:135509
Mtf1Thyls-BALB/c/Mtf1Thyls-BALB/c
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:71358
Mtf1Thyls-BALB/c/Mtf1Thyls-MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:85264, J:71358
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg) 		increased B cell derived lymphoma incidence J:186118
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:212144
Mus81tm1Raz/Mus81+
(involves: 129P2/OlaHsd) 		increased lymphoma incidence J:91570
Mus81tm1Raz/Mus81tm1Raz
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:91570
increased lymphoma incidence J:91570
Mutyhtm1Jhmi/Mutyhtm1Jhmi
Ogg1tm1Tld/Ogg1tm1Tld
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:89742
Myctm1Lbox/Myc+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
Myctm1Lbox/Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased B cell derived lymphoma incidence J:97900
Myh14tm2Rsad/Myh14+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:171110
Myh14tm2Rsad/Myh14tm2Rsad
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:171110
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:195140
increased T cell derived lymphoma incidence J:195140
Nabp2tm1Schg/Nabp2tm1Schg
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:228558
Nbnem3Jpt/Nbnem3Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:251434
Nbnem4Jpt/Nbnem4Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:251434
Nbnem7Jpt/Nbntm2Zqw
Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:277750
Nbntm1Jpt/Nbntm1Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased lymphoma incidence J:75956
Nbntm1Xu/Nbntm1Xu
(Not Specified) 		increased T cell derived lymphoma incidence J:75272
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:86563
increased lymphoma incidence J:86563
increased T cell derived lymphoma incidence J:86563
Nbntm2Zqw/Nbntm2Zqw
Trp53tm1Brd/Trp53tm1Brd
Tg(Nes-cre)1Wme/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA) 		increased lymphoma incidence J:98316
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		increased B cell derived lymphoma incidence J:109522
increased lymphoma incidence J:109522
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rragatm2Dmsa/Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:213516
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
Nf1tm1Fcr/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:58877
Nf1tm1Fcr/Nf1+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:58877
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:18542
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:217077
Nf1tm1Tyj/Nf1+
Suz12Gt(Betageo)1Khe/Suz12+
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:217077
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:217077
increased lymphoma incidence J:228258, J:217077
Nf2tm1Tyj/Nf2+
(either: (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) or (involves: 129S2/SvPas * C57BL/6J)) 		increased lymphoma incidence J:47282
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:132943
Nhej1tm1Fwa/Nhej1tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129) 		increased B cell derived lymphoma incidence J:138774
increased T cell derived lymphoma incidence J:138774
Nme1tm1Jyd/Nme1tm1Jyd
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:109190
Npm1tm1Gsva/Npm1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:172071
Npm1tm1Ppp/Npm1+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:101494
Nrbp1tm1.1Dja/Nrbp1tm1.1Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J) 		increased lymphoma incidence J:184685
Nrbp1tm1.1Dja/Nrbp1tm1.2Dja
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:184685
Nsmce2Gt(AA0032)Wtsi/Nsmce2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased histiocytic sarcoma incidence J:227197
increased lymphoma incidence J:227197
Pcbp4Gt(D136D11)Wrst/Pcbp4+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
Pcbp4Gt(D136D11)Wrst/Pcbp4Gt(D136D11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:231514
Pdcd4tm1Yhcn/Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		increased B cell derived lymphoma incidence J:120583
Per2tm1Brd/Per2tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:79456
Pigatm1Bsl/Y
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
Pigatm1Bsl/Piga+
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * C57BL/6 * CBA/Ca) 		increased B cell derived lymphoma incidence J:71354
Pinx1tm1.1Kplu/Pinx1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased histiocytic sarcoma incidence J:171997
increased lymphoma incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:171997
Pinx1tm1.1Kplu/Pinx1+
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased lymphoma incidence J:171997
Pknox1tm1Ngc/Pknox1+
Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased B cell derived lymphoma incidence J:192251
Plcg2tm1Jni/Plcg2tm1Jni
Tg(IghMyc)22Bri/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:117023
increased lymphoma incidence J:117023
Plk1Gt(RRR358)Byg/Plk1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:142593
Pmltm1.1Ews/Pmltm1.1Ews
(involves: 129 * 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:262172
increased T cell derived lymphoma incidence J:262172
Pmltm1Ppp/Pml+
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504
increased T cell derived lymphoma incidence J:317504
Pmltm1Ppp/Pmltm1Ppp
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:46381
Pmltm1Ppp/Pmltm1Ppp
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504
increased T cell derived lymphoma incidence J:317504
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased B cell derived lymphoma incidence J:162378
increased lymphoma incidence J:162378
increased T cell derived lymphoma incidence J:162378
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:27389
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas) 		increased B cell derived lymphoma incidence J:162378
increased lymphoma incidence J:125218
Pms2tm1Lisk/Pms2tm1Lisk
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		increased lymphoma incidence J:125218
Pold1tm1.1Bdp/Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp) 		increased lymphoma incidence J:153684
increased T cell derived lymphoma incidence J:153684
Pold1tm1.1Bdp/Pold1tm1.1Bdp
Poletm1.1Bdp/Poletm1.1Bdp
(B6.129-Poletm1.1Bdp Pold1tm1.1Bdp) 		increased T cell derived lymphoma incidence J:153684
Pold1tm1Bdp/Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:80306, J:100685
increased T cell derived lymphoma incidence J:100685
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N) 		increased lymphoma incidence J:261973
increased T cell derived lymphoma incidence J:261973
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
Trp53tm1Brd/Trp53+
(involves: C57BL/6J * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:261973
Poletm1.1Bdp/Poletm1.1Bdp
(B6.129-Poletm1.1Bdp) 		increased histiocytic sarcoma incidence J:153684
increased lymphoma incidence J:153684
Polgtm1Jiha/Polg+
(involves: C57BL/6JJcl) 		increased B cell derived lymphoma incidence J:199416
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		increased lymphoma incidence J:213427
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
increased lymphoma incidence J:71406
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased B cell derived lymphoma incidence J:71406
increased lymphoma incidence J:71406
Prdm11tm1.1Ahl/Prdm11tm1.1Ahl
Tg(IghMyc)22Bri/0
(B6.Cg-Prdm11tm1.1Ahl Tg(IghMyc)22Bri) 		increased B cell derived lymphoma incidence J:221379
Prdx1tm1Rave/Prdx1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased histiocytic sarcoma incidence J:84677
increased lymphoma incidence J:84677
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased B cell derived lymphoma incidence J:84677
increased histiocytic sarcoma incidence J:84677
increased lymphoma incidence J:84677
increased T cell derived lymphoma incidence J:84677
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz) 		increased B cell derived lymphoma incidence J:77491
increased lymphoma incidence J:77491
Prf1tm1Sdz/Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		increased lymphoma incidence J:77491
increased T cell derived lymphoma incidence J:77491
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid) 		increased T cell derived lymphoma incidence J:6958
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid) 		increased T cell derived lymphoma incidence J:109833, J:22026
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:53765
Psmb9tm1Stl/Psmb9tm1Stl
Trp53tm1Brd/Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:67509
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:205254
Ptentm1.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased lymphoma incidence J:170965
Ptentm1.2Mwst/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:63478
increased T cell derived lymphoma incidence J:50437
Ptentm1Mak/Pten+
(B6.129P2-Ptentm1Mak) 		increased lymphoma incidence J:93530
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:53065
Ptentm2.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased lymphoma incidence J:158751
increased T cell derived lymphoma incidence J:158751
Ptentm2Mak/Ptentm2Mak
Tg(Cyp1a1-cre)1Dwi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:143082
Ptpn11tm1Ckq/Ptpn11+
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:177285
Ptpn11tm1Ckq/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:177285
increased lymphoblastic lymphoma incidence J:177285
Ptprctm1Holm/Ptprctm1Holm
Tg(Lck*F505)2964Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
Ptprctm1Holm/Ptprctm1Holm
Tg(Lck*F505)3073Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
Puf60tm1.1Kmtsu/Puf60+
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
Rad50tm1Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Rad50tm2Jpt/Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		increased T cell derived lymphoma incidence J:78820
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:103922
Rad50tm2Jpt/Rad50tm2Jpt
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:78820
Rag1tm1Jsek/Rag1tm1Jsek
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:146912
Rag1tm1Mom/Rag1+
Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag1tm1Mom/Rag1+
Tg(LPV-TAg1135)11Tvd/0
Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag1tm1Mom/Rag1tm1Mom
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz) 		increased T cell derived lymphoma incidence J:109843
Rag1tm1Mom/Rag1tm1Mom
Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag1tm1Mom/Rag1tm1Mom
Tg(LPV-TAg1135)11Tvd/0
Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased T cell derived lymphoma incidence J:141515
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased T cell derived lymphoma incidence J:141515
Rag2tm1.1Desi/Rag2tm1.1Desi
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:168974
increased T cell derived lymphoma incidence J:168974
Rag2tm1.1Mss/Rag2tm1.1Mss
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased lymphoma incidence J:170462
increased T cell derived lymphoma incidence J:170462
Rag2tm1Fwa/Rag2+
Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag2tm1Fwa/Rag2+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased T cell derived lymphoma incidence J:235890
Rag2tm1Fwa/Rag2tm1Fwa
Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
Rag2tm1Fwa/Rag2tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
Rag2tm2.1Desi/Rag2tm2.1Desi
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:168974
Rarres1tm1.2Mhl/Rarres1+
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss) 		increased follicular lymphoma incidence J:324270
Rarres1tm1d(KOMP)Wtsi/Rarres1+
(involves: C57BL/6N) 		increased follicular lymphoma incidence J:324270
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl) 		increased lymphoma incidence J:202603
Rassf1tm1.2Brd/Rassf1tm1.2Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:101369
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ * C57BL/6) 		increased B cell derived lymphoma incidence J:95683
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased B cell derived lymphoma incidence J:168749
Rb1tm1.1Jyjw/Rb1tm1.1Jyjw
Trp53tm1Tyj/Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased lymphoma incidence J:102483
Rb1tm3Fad/Rb1tm3Fad
(involves: 129S1/Sv * 129X1/SvJ) 		increased lymphoma incidence J:249124
Rbbp8tm1Whl/Rbbp8+
(Not Specified) 		increased lymphoma incidence J:97648
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N) 		increased lymphoma incidence J:216929
Rbm38tm1.1Xch/Rbm38tm1.1Xch
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		increased lymphoma incidence J:216929
Rc3h1san/Rc3h1+
(involves: C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
Rcbtb2tm1.1Xyw/Rcbtb2+
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
increased lymphoma incidence J:282928
Rcbtb2tm1.1Xyw/Rcbtb2tm1.1Xyw
(involves: C57BL/6 * CBA) 		increased histiocytic sarcoma incidence J:282928
increased lymphoma incidence J:282928
Recql4tm1Glu/Recql4tm1Glu
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:97101
Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53tm1Brd
Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:158922
Rgsc142/Rgsc142+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased T cell derived lymphoma incidence J:133634
Rint1tm1Whl/Rint1+
(Not Specified) 		increased lymphoma incidence J:122805
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:161240
increased T cell derived lymphoma incidence J:161240
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:161240
increased T cell derived lymphoma incidence J:161240
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:198260
Robo1tm1Phr/Robo1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:93666
Rpa1tm1Wed/Rpa1+
(involves: 129/Sv * C57BL/6J * SJL) 		increased lymphoma incidence J:99303
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased B cell derived lymphoma incidence J:223276
increased T cell derived lymphoma incidence J:223276
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6N) 		increased lymphoma incidence J:223276
Rr149356tm1Che/Rr149356tm1Che
Tcrdtm1Mom/Tcrdtm1Mom
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
Rtel1tm2.1Hdin/Rtel1tm2.1Hdin
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:202812
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:106800
Runx1tm1Spe/Runx1+
(either: (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/Ca) or (involves: 129S4/SvJae * C57BL/6 * CBA/Ca)) 		increased T cell derived lymphoma incidence J:80829
Runx1tm2Buch/Runx1tm2Buch
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased lymphoma incidence J:105709
increased T cell derived lymphoma incidence J:105709
Runx1tm3Dow/Runx1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:77129
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6) 		increased B cell derived lymphoma incidence J:154439
S1pr2tm1Ajml/S1pr2tm1Ajml
(129S5/SvEvBrd-S1pr2tm1Ajml) 		increased B cell derived lymphoma incidence J:154439
S100a4tm1Amba/S100a4tm1Amba
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased lymphoma incidence J:89563
Sav1tm1Dlim/Sav1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased lymphoma incidence J:160325
Sirt1tm1.1Cxd/Sirt1+
Trp53tm1Brd/Trp53+
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N)) 		increased lymphoma incidence J:140089
Sirt2tm1.1Cxd/Sirt2tm1.1Cxd
(either: (involves: C57BL/6 * FVB/N) or (involves: FVB/N * NIH Black Swiss)) 		increased B cell derived lymphoma incidence J:177486
Skitm1Cco/Ski+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:73349
Skiltm1Sis/Skil+
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:62174
increased T cell derived lymphoma incidence J:62174
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased histiocytic sarcoma incidence J:179286
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:211266
Smarcb1tm1Sho/Smarcb1tm3Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA) 		increased lymphoma incidence J:80224
increased T cell derived lymphoma incidence J:80224
Smg1Gt(AG0297)Wtsi/Smg1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:193626
increased lymphoma incidence J:193626
Smurf2Gt(RRA098)Byg/Smurf2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased lymphoma incidence J:189320
Smurf2Gt(RRA098)Byg/Smurf2Gt(RRA098)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:189320, J:245679
increased lymphoma incidence J:189320
Sod2tm1Cje/Sod2+
(B6.Cg-Sod2tm1Cje/Mmmh) 		increased lymphoma incidence J:87514
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:90331
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:106040
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:90331
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac) 		increased lymphoma incidence J:166879
Srpxtm1Hzi/Srpx+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:119999
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:119999
increased T cell derived lymphoma incidence J:119999
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6) 		increased B cell derived lymphoma incidence J:162035
increased lymphoma incidence J:162035
Ssbp2tm1Lana/Ssbp2tm1Lana
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:162035
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas) 		increased histiocytic sarcoma incidence J:184720
increased lymphoma incidence J:184720
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(involves: 129 * C57BL/6) 		increased histiocytic sarcoma incidence J:153945
Stk11tm1.1Mlfr/Stk11+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoma incidence J:104347
Stk38tm1Hem/Stk38+
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
Stk38tm1Hem/Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
SufuGt(XB699)Byg/Sufu+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:125534
Suv39h1tm1Jnw/Suv39h1+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1+
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1+
Suv39h2tm1Jnw/Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h1tm1Jnw/Suv39h1tm1Jnw
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h2tm1Jnw/Suv39h2+
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suv39h2tm1Jnw/Suv39h2tm1Jnw
(involves: 129 * C57BL/6J) 		increased B cell derived lymphoma incidence J:72503
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd) 		increased histiocytic sarcoma incidence J:217077
Tbrg1tm1a(KOMP)Wtsi/Tbrg1tm1a(KOMP)Wtsi
(C57BL/6N-Tbrg1tm1a(KOMP)Wtsi) 		increased B cell derived lymphoma incidence J:225146
Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S4/SvJaeSor * C57BL/6) 		increased T cell derived lymphoma incidence J:44278
Tcf3tm2Wein/Tcf3tm2Wein
(Not Specified) 		increased T cell derived lymphoma incidence J:47671
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		increased lymphoma incidence J:125218
Tg(ACTB-Eif4e)#Ppp/?
(Not Specified) 		increased B cell derived lymphoma incidence J:89878
Tg(ACTB-Eif4e)#Ppp/0
Tg(IghMyc)22Bri/0
(involves: C57BL * SJL) 		increased lymphoma incidence J:89878
Tg(BCL2)22Wehi/0
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi) 		increased lymphoma incidence J:69571
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased T cell derived lymphoma incidence J:93111
Tg(BCL2/IGH)#Jcre/0
Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J) 		increased small lymphocytic lymphoma incidence J:94116
Tg(BCR/ABL)623Hkp/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:89786
Tg(BCR/ABL)623Hkp/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:76680
Tg(CD2-NPM/ALK)4Sudt/0
(involves: C57BL/6J * CBA) 		increased B cell derived lymphoma incidence J:181238
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci) 		increased T cell derived lymphoma incidence J:93665
Tg(Cd4-NPM/ALK)N1Ingh/0
(either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster)) 		increased lymphoblastic lymphoma incidence J:82127
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		increased T cell derived lymphoma incidence J:235890
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		increased B cell derived lymphoma incidence J:79703
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased histiocytic sarcoma incidence J:94953
increased lymphoma incidence J:94953
Tg(Emu-Pim1)64aBrn/0
(involves: C57BL/6LiA * CBA) 		increased lymphoma incidence J:79624
increased T cell derived lymphoma incidence J:79624
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		increased B cell derived lymphoma incidence J:117018
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:237420
increased histiocytic sarcoma incidence J:237420
increased splenic marginal zone lymphoma incidence J:237420
Tg(EmuSR-tTa)83Bop/0
Tg(IghMyc)22Bri/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: C57BL * C57BL/6 * FVB/N * SJL) 		increased lymphoma incidence J:123006
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop
Tg(tetO-NPM1/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop
Tg(tetO-TPM3/ALK,-luc)2Gde/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:160236
Tg(H2-K-Hmga1)#Lmsr/0
(involves: C57BL/6 * SJL) 		increased lymphoma incidence J:90252, J:121308
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C.B6-Tg(H2-L-IL6)46Kish) 		increased B cell derived lymphoma incidence J:74377
increased follicular lymphoma incidence J:74377
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6) 		increased lymphoma incidence J:64968
Tg(HRAS)7Mok/?
(involves: C57BL/6) 		increased lymphoma incidence J:64968
Tg(Igh*-Mir125b-1)5Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
increased lymphoma incidence J:178816
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		increased B cell derived lymphoma incidence J:178816
increased lymphoma incidence J:178816
increased T cell derived lymphoma incidence J:178816
Tg(Igh-HOX11)11Idd/0
(CD-1) 		increased B cell derived lymphoma incidence J:52782
Tg(Igh-Maf)68Staka/0
(C57BL/6-Tg(Igh-Maf)68Staka) 		increased lymphoma incidence J:168074
Tg(Igh-Maf)524Staka/0
(involves: C57BL/6 * C57BL/6J * DBA/2) 		increased lymphoma incidence J:168074
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:109591
increased lymphoblastic lymphoma incidence J:109591
Tg(Igh-Pim1)1Brn/0
(involves: C57BL/6LiA * CBA) 		increased lymphoma incidence J:79624
increased T cell derived lymphoma incidence J:79624
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:121564
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:186117, J:78177
increased lymphoma incidence J:78177, J:223213
Tg(IghMyc)22Bri/0
(B6.Cg-Tg(IghMyc)22Bri/J) 		increased lymphoma incidence J:164200
Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6 * SJL) 		increased lymphoma incidence J:117023
Tg(IghMyc)22Bri/0
(involves: C57BL/6N * SJL) 		increased lymphoma incidence J:214383
Tg(IghMyc)22Bri/0
Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N) 		increased B cell derived lymphoma incidence J:89049
Tg(IghMyc)22Bri/0
Tg(Lck/Emu-Eif4e)#Ppp/0
(involves: C57BL * SJL) 		increased lymphoma incidence J:89878
Tg(IghMyc)22Bri/0
Trp53tm1Tyj/Trp53+
(involves: 129/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL) 		increased B cell derived lymphoma incidence J:125164
Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh) 		increased B cell derived lymphoma incidence J:131912
Tg(Igkv3-5-MYC)#Plbe/0
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:131912
Tg(IGL-MYC)3Hm/0
(C57BL/6N-Tg(IGL-MYC)3Hm/Nci) 		increased B cell derived lymphoma incidence J:65245
Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6) 		increased lymphoma incidence J:196403
Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6) 		increased T cell derived lymphoma incidence J:73487
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6) 		increased T cell derived lymphoma incidence J:73487
Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified) 		increased T cell derived lymphoma incidence J:144975
Tg(Lck-Akt2*)#Test/0
(Not Specified) 		increased lymphoma incidence J:154583
increased T cell derived lymphoma incidence J:153923
Tg(Lck-Id1)28Xhsu/0
(Not Specified) 		increased T cell derived lymphoma incidence J:58607
Tg(Lck-LMO1)11Sjk/0
Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		increased T cell derived lymphoma incidence J:40868
Tg(Lck-Map3k8)3456Ngc/?
(involves: C3H/HeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:39450
Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2) 		increased lymphoblastic lymphoma incidence J:63300
increased T cell derived lymphoma incidence J:96010
Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led) 		increased lymphoblastic lymphoma incidence J:36076
Tg(Lck-Tax)53Hall/0
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:129531
Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J) 		increased T cell derived lymphoma incidence J:93005
Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6) 		increased T cell derived lymphoma incidence J:28635
Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL) 		increased follicular lymphoma incidence J:69755
increased lymphoma incidence J:69755
increased T cell derived lymphoma incidence J:69755
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:51661
Tg(Mdm2)1Snj/0
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:51661
Tg(MMTV-Cdc37)1Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
Tg(MMTV-Cdc37)1Stp/0
Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6 * CD-1 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
Tg(MMTV-Cdc37)2Stp/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:62465
Tg(MMTV-Myc)141-3Led/0
(involves: C57BL/6J * CD-1) 		increased B cell derived lymphoma incidence J:62465
Tg(MtTPRMET)243Lng/0
(FVB/N-Tg(MtTPRMET)243Lng) 		increased lymphoma incidence J:71573
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N) 		increased T cell derived lymphoma incidence J:17848
Tg(SV40-NRAS*G12D)1Sco/?
(Not Specified) 		increased T cell derived lymphoma incidence J:125150
Tg(SV)419Bri/Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri) 		increased T cell derived lymphoma incidence J:147031
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N) 		increased B cell derived lymphoma incidence J:55022
increased T cell derived lymphoma incidence J:55022
Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6) 		increased lymphoma incidence J:92992
Tg(Tek-cre)1Ywa/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased lymphoma incidence J:96511
Tg(Thy1-cmyc)6Kio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
Tg(Thy1-cmyc)6LKio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:189197
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat) 		increased lymphoma incidence J:257519
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		increased B cell derived lymphoma incidence J:88565, J:228913
increased follicular lymphoma incidence J:88565, J:228913
increased histiocytic sarcoma incidence J:88565
increased lymphoma incidence J:88565
increased T cell derived lymphoma incidence J:88565
Tg(WapTgfa)215Bri/0
(B6.Cg-Tg(WapTgfa)215Bri) 		increased lymphoma incidence J:123146
Tgfbitm1Zhao/Tgfbitm1Zhao
(involves: 129 * C57BL/6J) 		increased lymphoma incidence J:143036
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391
Thbs1tm1Hyn/Thbs1tm1Hyn
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391
ThimTg(Myh6-TGFB1)1Ljf/Thim+
(involves: C3HeB/FeJ) 		increased T cell derived lymphoma incidence J:59903
Thyls2MSM/Thyls2MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:87704
Tlag2AKR/J/Tlag2C57L/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
Tlag2AKR/J/Tlag2C57L/J
Tlag1AKR/J/Tlag1AKR/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		increased splenic marginal zone lymphoma incidence J:324448
Tlsm1AKR/JMs/Tlsm1AKR/JMs
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
Tlsm1AKR/JMs/Tlsm1SL/Kh
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
Tmprss11dtm1Bug/Tmprss11dtm1Bug
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		increased lymphoma incidence J:175364
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		increased lymphoma incidence J:140639
Tnk1tm1Sksuf/Tnk1tm1Sksuf
(involves: 129X1/SvJ * C57BL/6) 		increased B cell derived lymphoma incidence J:140639
increased lymphoma incidence J:140639
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		increased lymphoma incidence J:184948
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		increased lymphoma incidence J:232482
Trim62tm1Akil/Trim62+
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:204336
Trim62tm1Akil/Trim62tm1Akil
(involves: 129S/SvEv * C57BL/6) 		increased lymphoma incidence J:204336
Trp53Bbl/Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased lymphoma incidence J:104190
increased T cell derived lymphoma incidence J:104190
Trp53Bbl/Trp53Bbl
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased B cell derived lymphoma incidence J:104190
Trp53bhy/Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu) 		increased lymphoma incidence J:104190
increased T cell derived lymphoma incidence J:104190
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
increased follicular lymphoma incidence J:169434
increased histiocytic sarcoma incidence J:173271
increased T cell derived lymphoma incidence J:173271
Trp53tm1.1Brn/Trp53tm3Tyj
Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N * SKH1) 		increased lymphoma incidence J:121734
Trp53tm1.1Thst/Trp53+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL * SJL) 		increased lymphoma incidence J:198482
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
Trp53tm1.1Umol/Trp53tm1.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
Trp53tm1.1Xlu/Trp53tm1.1Xlu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * FVB/N) 		increased lymphoma incidence J:166152
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:173271
increased histiocytic sarcoma incidence J:173271
increased T cell derived lymphoma incidence J:173271
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:73757
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:51661
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:1999
increased T cell derived lymphoma incidence J:126497
Trp53tm1Brd/Trp53tm1Brd
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:157041
Trp53tm1Brd/Trp53tm1Brd
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:109585
Trp53tm1Brd/Trp53tm1Brd
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased lymphoma incidence J:141515
Trp53tm1Brd/Trp53tm1Ldo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:73757
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB) 		increased lymphoma incidence J:162126
Trp53tm1Elee/Trp53tm1Elee
Tg(MMTV-cre)AElee/0
(involves: 129S4/SvJae * C57BL/6) 		increased lymphoma incidence J:90247
Trp53tm1Gev/Trp53tm1Gev
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:99305
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:61683
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd) 		increased lymphoma incidence J:129627
Trp53tm1Glo/Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:61683
Trp53tm1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
increased T cell derived lymphoma incidence J:171821
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:36762
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
Trp53tm1Thst/Trp53+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * SJL) 		increased lymphoma incidence J:198482
Trp53tm1Thst/Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased histiocytic sarcoma incidence J:72391
increased lymphoma incidence J:72391, J:17728
Trp53tm1Tyj/Trp53+
Trp53bp2tm1Xlu/Trp53bp2+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J) 		increased lymphoma incidence J:108701
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
Trp53tm1Tyj/Trp53+
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: 129S2/SvPas * BALB/cJ * C57BL/6) 		increased lymphoma incidence J:191827
Trp53tm1Tyj/Trp53+
Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:111068
Trp53tm1Tyj/Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:72391, J:17728, J:95318
increased T cell derived lymphoma incidence J:87501, J:17728
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased lymphoma incidence J:221224
increased T cell derived lymphoma incidence J:251434, J:221224, J:88120, J:95316
Trp53tm1Tyj/Trp53tm1Tyj
(129S6.129-Trp53tm1Tyj Rb1tm1.1Jyjw) 		increased lymphoma incidence J:102483
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Ly6e-MALT1)#Isg/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		increased B cell derived lymphoma incidence J:185590
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased lymphoma incidence J:111068
increased T cell derived lymphoma incidence J:111068
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas) 		increased B cell derived lymphoma incidence J:61973
Trp53tm1Tyj/Trp53tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
Trp53tm1Tyj/Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
Trp53tm1Tyj/Trp53tm3.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
Trp53tm1Yjc/Trp53tm1Yjc
(B6.129S1-Trp53tm1Yjc) 		increased splenic marginal zone lymphoma incidence J:195018
Trp53tm2.1Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
increased T cell derived lymphoma incidence J:282255
Trp53tm2.1Umol/Trp53tm2.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased B cell derived lymphoma incidence J:228632
increased T cell derived lymphoma incidence J:228632
Trp53tm2Glo/Trp53tm2Glo
(involves: 129/Sv * C57BL/6) 		increased lymphoma incidence J:87501
Trp53tm2Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased B cell derived lymphoma incidence J:282255
increased T cell derived lymphoma incidence J:282255
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased B cell derived lymphoma incidence J:317504
increased lymphoma incidence J:317504, J:95318
increased T cell derived lymphoma incidence J:317504
Trp53tm3.1Glo/Trp53tm3.1Glo
(B6.129S7-Trp53tm3.1Glo) 		increased lymphoma incidence J:95318
Trp53tm3.1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae) 		increased B cell derived lymphoma incidence J:95316
Trp53tm3Tyj/Trp53+
Tg(KRT14-cre)8Brn/?
(involves: 129S4/SvJae * FVB/N * SKH1) 		increased lymphoma incidence J:121734
Trp53tm3Tyj/Trp53+
Tg(Wap-cre)11738Mam/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased lymphoma incidence J:101617
Trp53tm4Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased lymphoma incidence J:171821
increased T cell derived lymphoma incidence J:171821
Trp53tm4Tyj/Trp53tm4Tyj
(involves: 129S4/SvJae * C57BL/6) 		increased B cell derived lymphoma incidence J:92917
Trp53tm4Xu/Trp53tm4Xu
(Not Specified) 		increased lymphoma incidence J:126497
increased T cell derived lymphoma incidence J:126497
Trp53tm6Xu/Trp53tm6Xu
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		increased lymphoma incidence J:157041
increased T cell derived lymphoma incidence J:157041
Trp53tm7.1Xu/Trp53tm7.1Xu
(Not Specified) 		increased lymphoma incidence J:160414
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6) 		increased lymphoma incidence J:82512
increased T cell derived lymphoma incidence J:82512
Trp53bp2tm1Cdlo/Trp53bp2+
Tg(EmuSR-tTa)83Bop/0
Tg(tetO-MYC)36aBop/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:146764
Trp53bp2tm1Xlu/Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lymphoma incidence J:108701
increased T cell derived lymphoma incidence J:108701
Trp63tm1Fmc/Trp63+
(involves: 129S4/SvJae * C57BL/6) 		increased histiocytic sarcoma incidence J:98958
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
Trp73tm1Mak/Trp73+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:142848
increased T cell derived lymphoma incidence J:142848
Trp73tm1Mak/Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoma incidence J:142848
increased T cell derived lymphoma incidence J:142848
Ts(16C-tel)1Cje/0
(involves: C57BL/6J * Rb(11.16)2H * Rb(16.17)32Lub) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
Ts(1716)65Dn/0
(involves: C3H/HeJ * C57BL/6J * DBA/2J) 		increased follicular lymphoma incidence J:174270
increased lymphoma incidence J:174270
TsilTg(Myc)12ALvn/Tsil+
(involves: C57BL/6 * SJL/J) 		increased lymphoma incidence J:33857
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		increased lymphoma incidence J:119985
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Ptentm1Ppp/Ptentm1Ppp
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N) 		increased lymphoma incidence J:239679
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6N * FVB/N * SJL) 		increased B cell derived lymphoma incidence J:239679
Uimc1Gt(RRN158)Byg/Uimc1Gt(RRN158)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased B cell derived lymphoma incidence J:188388
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6) 		increased B cell derived lymphoma incidence J:191827
increased lymphoma incidence J:191827
increased T cell derived lymphoma incidence J:191827
Ungtm1Tld/Ungtm1Tld
(Not Specified) 		increased B cell derived lymphoma incidence J:85353
Usp44tm1.2Pjgl/Usp44tm1.2Pjgl
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased lymphoma incidence J:193965
WwoxGt(XG218)Byg/WwoxGt(XG218)Byg
(involves: 129P2/OlaHsd) 		increased B cell derived lymphoma incidence J:132078
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:44361
Zeb1tm1Yhi/Zeb1tm1Yhi
(either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR)) 		increased T cell derived lymphoma incidence J:139194
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6) 		increased B cell derived lymphoma incidence J:331393
Zfp36l1tm1.1Tnr/Zfp36l1tm1.1Tnr
Zfp36l2tm1.1Tnr/Zfp36l2tm1.1Tnr
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL) 		increased T cell derived lymphoma incidence J:162388
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		increased B cell derived lymphoma incidence J:317166
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/23/2024
MGI 6.23 		The Jackson Laboratory